Teleflex reports Q4 adjusted EPS $3.38, consensus $3.26

Reports Q4 revenue $773.9M, consensus $768.69M. “We demonstrated solid execution during the fourth quarter against a stable to improving macro-environment,” said CEO Liam Kelly. “We once again built upon Teleflex’s growth objectives which resulted in 6.5% constant currency revenue growth for 2023. During the year, we expanded our geographic presence, launched new products, and continued to drive efficiencies throughout the business. In addition, we advanced our capital allocation strategy with the close of the Palette Life Sciences AB acquisition in October, 2023 and our integration activities are progressing well. As we look into 2024, we remain committed to our corporate strategy for durable growth.”